Literature DB >> 11010698

Race and ethnic variation in the disablement process.

B A Zsembik1, M K Peek, C W Peek.   

Abstract

OBJECTIVES: This analysis examines ethnoracial group differences in the transition from health to disability.
METHODS: Using data from the AHEAD study, the authors examine the relative influence of each stage in the disablement process in the evolution of ethnoracial group differences in basic and instrumental disability.
RESULTS: Predisposing factors account for disability differences between Whites and other Latinos, whereas excess disability among African Americans stems from their higher level of cognitive limitation. The excess disability of Mexican Americans arises from their higher level of physical limitations. The data also reveal a larger impact of medical conditions and physical limitations on acquisition of disability among African Americans and Mexican Americans. This article demonstrates the importance of cognitive status in the disablement process, especially in ethnoracial group differences. DISCUSSION: The authors discuss the practical implications for health care delivery to non-White elders and the theoretical implications for understanding the complexities of disablement.

Entities:  

Mesh:

Year:  2000        PMID: 11010698     DOI: 10.1177/089826430001200205

Source DB:  PubMed          Journal:  J Aging Health        ISSN: 0898-2643


  15 in total

1.  Motor Function Is Associated With Incident Disability in Older African Americans.

Authors:  Aron S Buchman; Robert S Wilson; Lei Yu; Patricia A Boyle; David A Bennett; Lisa L Barnes
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-11-02       Impact factor: 6.053

2.  Is the effect of reported physical activity on disability mediated by cognitive performance in white and african american older adults?

Authors:  Mihaela A Popa; Sandra L Reynolds; Brent J Small
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-02-04       Impact factor: 4.077

3.  Ethnicity and changing functional health in middle and late life: a person-centered approach.

Authors:  Jersey Liang; Xiao Xu; Joan M Bennett; Wen Ye; Ana R Quiñones
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-12-14       Impact factor: 4.077

4.  Disability and health: exploring the disablement experience of young adult African Americans.

Authors:  Tiffany N Ricks; Tracie Harrison
Journal:  Disabil Rehabil       Date:  2013-06-07       Impact factor: 3.033

5.  Executive function processes predict mobility outcomes in older adults.

Authors:  Neha P Gothe; Jason Fanning; Elizabeth Awick; David Chung; Thomas R Wójcicki; Erin A Olson; Sean P Mullen; Michelle Voss; Kirk I Erickson; Arthur F Kramer; Edward McAuley
Journal:  J Am Geriatr Soc       Date:  2014-01-21       Impact factor: 5.562

6.  Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study.

Authors:  J S Gewandter; L Fan; A Magnuson; K Mustian; L Peppone; C Heckler; J Hopkins; M Tejani; G R Morrow; S G Mohile
Journal:  Support Care Cancer       Date:  2013-02-28       Impact factor: 3.603

7.  Driving life expectancy of persons aged 70 years and older in the United States.

Authors:  Daniel J Foley; Harley K Heimovitz; Jack M Guralnik; Dwight B Brock
Journal:  Am J Public Health       Date:  2002-08       Impact factor: 9.308

8.  Activities of daily living in Mexican American caregivers: the key to continuing informal care.

Authors:  Bronwynne C Evans; Michael J Belyea; David W Coon; Ebere Ume
Journal:  J Fam Nurs       Date:  2012-06-26       Impact factor: 3.818

9.  Progressive and accelerated disability onset by race/ethnicity and education among late midlife and older adults.

Authors:  Kenzie Latham
Journal:  J Aging Health       Date:  2012-09-14

10.  Functional limitations and depressive symptoms: a longitudinal analysis of older Mexican American couples.

Authors:  Maria A Monserud; M Kristen Peek
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2014-05-13       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.